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Abstract
The present study evaluated electrocardiographic alterations in rats with epilepsy submitted to an acute myocardial infarction (AMI)
model induced by cardiac ischemia and reperfusion. Rats were randomly divided into two groups: control (n=12) and epilepsy
(n=14). It was found that rats with epilepsy presented a significant reduction in atrioventricular block incidence following the
ischemia and reperfusion procedure. In addition, significant alterations were observed in electrocardiogram intervals during the
stabilization, ischemia, and reperfusion periods of rats with epilepsy compared to control rats. It was noted that rats with epilepsy
presented a significant increase in the QRS interval during the stabilization period in relation to control rats (P,0.01). During the
ischemia period, there was an increase in the QRS interval (P,0.05) and a reduction in the P wave and QT intervals (P,0.05 for
both) in rats with epilepsy compared to control rats. During the reperfusion period, a significant reduction in the QT interval
(P,0.01) was verified in the epilepsy group in relation to the control group. Our results indicate that rats submitted to an epilepsy
model induced by pilocarpine presented electrical conductivity alterations of cardiac tissue, mainly during an AMI episode.
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Introduction
Epilepsy is the most common chronic neurological
disorder, and people with epilepsy are two to three times
more likely to die prematurely when compared with people
without epilepsy (1-3). The most common epilepsy-related
category of death is sudden unexpected death in epilepsy
(SUDEP) (3,4), a leading cause of mortality in patients with
epilepsy. Although the cause of SUDEP is still unknown,
one of the main mechanisms of SUDEP is autonomic
dysregulation (i.e., cardiac abnormalities during and
between seizures) (5-7). Suspected mechanisms include
cardiac arrhythmia, central and/or obstructive apnea,
neurogenic pulmonary edema, and primary cessation of
brain activity (3,8-11). In fact, clinical seizures are often
accompanied by intense autonomic changes, and there is
evidence that sympathetic activity is increased even
interictally in patients with temporal lobe epilepsy
(10,12,13). Ictal tachycardia is the more frequent arrhyth-
mia (14,15), but ictal bradycardias, high-grade atrioven-
tricular block, and asystole are also observed (10,16,17).
Curiously, ictal bradyarrhythmia also appears to be
associated with a higher risk of SUDEP (10,18). Several
case reports have described asystole or bradycardia during
epileptic seizures and have linked these conditions to a
higher risk of SUDEP (19,20). Trying to explain these
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cardiac conduction abnormalities, P-Codrea Tigaran et al.
(21) performed a prospective setting case-control study of
all SUDEP cases in Denmark and verified that the SUDEP
cases displayed significant fibrosis of the myocardium. The
authors raised a hypothesis that this fibrosis could be the
consequence of myocardial ischemia as a direct result of
repetitive epileptic seizures, which, associated with the ictal
sympathetic storm, may lead to lethal arrhythmias. Other
studies also identified that epilepsy might be a risk and an
adverse prognostic factor for acute myocardial infarction
(AMI) (22,23).
Considering that the mechanisms underlying SUDEP
remain uncertain and that AMI risk and prognosis in
epilepsy have been poorly explored, it would be useful to
obtain, in an animal model, additional information about
cardiac alterations associated with epilepsy under AMI
conditions. Thus, we evaluated in vivo ventricular arrhyth-
mias (VA), atrioventricular block (AVB), and mortality in
rats with epilepsy submitted to an AMI model induced by
cardiac ischemia and reperfusion.
Material and Methods
Induction of epilepsy
Twenty-six male Wistar rats (280±30 g) were used in
this study. All experimental protocols described below
were approved by the Ethics Committee of the
Universidade Federal de Sa˜o Paulo (#1130/11). The
colony room was maintained at 21±26C with a 12:12-h
light/dark schedule, and the animals were given food and
water ad libitum throughout the experiments. Rats were
randomly divided into 2 groups: control (n=12) and
epilepsy (n=14). Rats from the epilepsy group were
submitted to a temporal lobe epilepsy model induced by a
single administration of pilocarpine hydrochloride
(350 mg/kg, ip; Sigma, USA) (24). Scopolamine methylni-
trate (1 mg/kg, sc; Sigma) was administered 30 min
before pilocarpine injection to limit peripheral cholinergic
effects (24). The systemic administration of potent
muscarinic agonist pilocarpine in rats promotes sequential
behavioral and electrographic changes that build up
progressively into a limbic status epilepticus (SE), which
lasts 24 h. During the SE, two rats died. Following this
acute period of the epilepsy model, the surviving animals
(n=12) were continuously monitored over 24 h for
detection of spontaneous recurrent seizures, using a
video system. After the first spontaneous recurrent
seizure had been detected, animals were monitored over
the following 120 days by two researchers in the
experimental room for observation periods ranging from
2 to 4 h. During this period, the only observation was
whether seizures were present in the rats (to ensure that
they were epileptic rats).
Ischemia and reperfusion protocol
After 120 days, animals from the control and epilepsy
groups were submitted to an AMI model induced by cardiac
ischemia and reperfusion similar to that previously described
(25). All rats were anesthetized with urethane (1.2 g/kg, ip)
and fixed in the supine position. After intubation with a
catheter (Jelco 14G, USA), rats were mechanically venti-
lated with room air with a stroke volume of approximately
10 ml/kg (,82 breaths min) using a ventilator (Insight EFF
312, Brazil). Under clean dissection, indwelling polyethylene
catheters were inserted into a common carotid artery. The
body temperature was maintained at 37.56C with a heated
operating platform and appropriate heating lamps, and was
monitored routinely via a rectal thermometer. The electro-
cardiogram (ECG) was recorded using a biopotential
amplifier by means of needle electrodes placed subcuta-
neously on the limbs. The chest was opened with a left
thoracotomy and the heart was gently exteriorized using
pressure on the abdomen. A ligature (4/0 braided silk suture
attached to a 10-mm micropoint reverse-cutting needle,
Ethicon K-890H, USA) was placed around the left anterior
descending coronary artery, approximately 2 mm from its
origin. A polyethylene tube was threaded over the suture
and the heart was replaced in the chest cavity with the
ligature ends exteriorized. After a stabilization period of
15 min, the ligature was tied, characterizing the ischemic
period, and, following a period of coronary occlusion
(10 min), the reperfusion was obtained by cutting the suture
(Figure 1). Successful ligation of the coronary artery was
validated by ECG alterations (increase in R wave and ST
segment) and reduction in arterial pressure (26,27).
Monitoring, recording, and ECG waveform analysis
The ECG of the rats was monitored and recorded from
the beginning of the stabilization period using a commercial
acquisition system (AqDados 7.02; Lynx Tecnologia Ltda.,
Brazil). The recorded raw data were evaluated using the
commercial software included in the acquisition system
(AqDAnalysis 7, Lynx Tecnologia Ltda.; Figure 1). Heart rate
as well as incidence of reperfusion-induced VA, AVB, and
lethality were measured. To simplify the presentation of the
results, ventricular fibrillation, torsades de pointes, and
ventricular tachycardia parameters were considered only as
VA. ECG measurements were evaluated according to
Lambeth conventions (28,29). P duration was manually
measured as the time from the beginning of the upstroke of
the P wave until its return to the isoelectric baseline. QRS
duration was measured from the beginning of the Q wave to
the peak amplitude of the downward deflection of the S
wave. PR interval was measured from the beginning of the
upstroke of the P wave until the maximal amplitude of the R
wave. RR interval was measured as the time between
consecutive R wave peaks. QT interval was measured from
the beginning of the Q wave until the T wave returned to the
isoelectric baseline (30).
Data analysis
In control and epilepsy groups, the incidences of VA,
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AVB, and lethality were compared with Fisher’s exact test.
Statistical analyses of ECG data were carried out by
analysis of variance followed by Bonferroni’s post hoc
test. Values were considered significant when P,0.05.
Statistical analyses were performed with the Prism 5.0
software (GraphPad, USA), and data are reported as
means±SE.
Results
Both control and epilepsy groups showed no arrhyth-
mias during stabilization. The arrhythmias were observed
and measured during ischemia and reperfusion (Table 1).
No significant difference was detected in the incidence of
VA and lethality between studied groups [VA inci-
dence=83.3% in the control group (10/12) and 75% in
the epilepsy group (9/12) P=1.00; lethality=66.7% in the
control group (8/12) and 58.3% in the epilepsy group (7/12)
P=1.00]. However, the incidence of AVB was significantly
lower in the epilepsy group [25% (3/12)] than in the control
group [83.3% (10/12) P=0.012; Table 1].
In the ECG waveform analysis, it was noted that rats
with epilepsy presented a significant increase in the QRS
interval during the stabilization period in relation to control
rats (P,0.01; Figure 2). During the ischemia period, a
significant increase in the QRS interval (P,0.05) and
reduction in P wave and QT intervals (P,0.05 in both) were
found in rats from the epilepsy group compared to rats from
the control group. During the reperfusion period, a
significant reduction in the QT interval (P,0.01) was
verified in the epilepsy group in relation to the control group.
Discussion
The present study evaluated electrocardiographic
alterations in rats with epilepsy submitted to an AMI
model induced by cardiac ischemia and reperfusion. Rats
with epilepsy presented a significant reduction in AVB
incidence following the ischemia and reperfusion proce-
dure. In addition, significant alterations were observed in
ECG intervals during the stabilization and ischemia and
reperfusion periods of rats with epilepsy compared to
control rats. Our results indicated that the rats submitted
to an epilepsy model induced by pilocarpine presented
electrical conductivity alterations of the cardiac tissue,
mainly during an AMI episode.
During the stabilization period, no abnormality in P
wave or PR, RR, and QT intervals was observed in rats
with epilepsy. However, a significant increase in the
interval of the QRS complex was noted in these animals,
which is indicative of conduction abnormalities. This result
showed that the period of ventricular depolarization is
Figure 1. Images of the experiment with ischemia and reperfusion and ECG measurements.
Table 1. Incidence of ventricular arrythmias (VA), atrioventricular block (AVB)
and lethality during reperfusion in 12 rats in each group.
Groups VA AVB Lethality
Control 10/12 10/12 8/12
Epilepsy 9/12 3/12* 7/12
*P,0.05, compared to the control group (Fisher’s exact test).
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already altered in the epilepsy group following stabilization.
This alteration could be related to different factors, such as
pathological fibrosis of the myocardium, morphological
abnormalities of the cardiac conduction system, or an
inappropriate autonomous nervous system response (3).
Indeed, some studies have suggested that SUDEP cases
in humans displayed significant fibrosis of the myocardium,
which is known to be the substrate leading to discontinuous
propagation and spatial dispersion of cardiac conduction
(31,32). Although no pathological analyses have been
performed in the present study, our experimental finding is
in agreement with reports showing a widening QRS
complex as a common cardiac abnormality in patients with
epilepsy (33).
During the ischemia and reperfusion periods, signifi-
cant alterations in PR and RR intervals between studied
groups were not observed. However, changes in the
incidence of AVB and in the P, QRS, and QT intervals
were found during the periods of ischemia and/or
reperfusion in animals with epilepsy. These results show
that the period of depolarization is different between
animals with epilepsy and controls in conditions of tissue
injury. We cannot explain the exact mechanism of the
decrease in AVB incidence in epileptic rats. However, it
might be related, at least in part, to the KV 1.1 potassium
channel, the deficiency of which leads to aberrant
parasympathetic neurotransmission and consists of a
candidate mechanism for AVB in epileptic animals (12). In
the control group, increases in the duration of cardiac
atrial or ventricular electrical activities (P wave and QT
interval) occur during periods of ischemia and reperfusion
compared to the stabilization period. In contrast, these
enlargements, which could lead to atrial fibrillation or
ventricular arrhythmias, such as torsades de pointes,
were not observed in the epilepsy group during ischemia
and reperfusion, leading to a significant difference
between groups. This result is interesting and intriguing.
It is possible that this particular ECG alteration in rats with
epilepsy is related to a compensatory cardiac mechanism.
Another possible explanation could be attributed to the
seizure effects on gene expression. The molecular
mechanism for the malignant brain-heart relationship
has remained elusive until the recent discovery of
arrhythmogenic mutations. Mutations in potassium
(KCNH2, KCNQ1, KCNJ2) and calcium channel subunit
genes have been identified to cause short QT syndrome
(SQTS) (34), which is a rare, sporadic, or autosomal
dominant disorder characterized by markedly accelerated
cardiac repolarization and is manifested by a dramatically
shortened QT interval, atrial and ventricular arrhythmias,
and sudden cardiac death. Although it has been recog-
nized for some time that prolongation of cardiac repolar-
ization is a substrate for arrhythmias, the link between
accelerated repolarization and arrhythmia has only
recently been established (34).
Considering that variations in ventricular action poten-
tial can lead to increased or decreased QT interval and
arrhythmias, it has been established that QT dispersion is a
significant predictor of cardiovascular mortality (5,35). In
our study in an animal model, a clear correlation between
QT enlargement and high incidence of VA and deaths was
found in the control group during ischemia and reperfusion.
Although the high incidence of mortality in both epilepsy
and control groups was noted, the lower QT interval did not
modify the mortality incidence in the epilepsy group during
ischemia and reperfusion, demonstrating that epilepsy did
Figure 2. Duration of P wave, and PR, QRS, QT
and RR intervals in rats from the control and
epilepsy groups during stabilization (Stab), ische-
mia (Isch) and reperfusion (Rep). *P,0.05,
compared to the control group; #P,0.05, com-
pared to the stabilization period (ANOVA fol-
lowed by Bonferroni’s post hoc test).
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not represent a high risk of lethal arrhythmias in this model.
Nevertheless, it is important to point out that the period of
injury has been greatly extended (10 min of ischemia) in
our experiments in order to observe significant differences
in lethality between the groups. It is probable that a less
aggressive stimulus could reveal more subtle differences.
Despite this, conductivity alterations of the cardiac tissue
were detected in rats with epilepsy following an ischemia
and reperfusion protocol. Our results suggest that epilepsy
can result in electrical conductivity alterations of the cardiac
tissue, mainly during an AMI episode.
Acknowledgments
Research supported by CNPq, FAPESP (#09/06953-
4) and Instituto Nacional de Neurocieˆncia Translacional
(INNT).
References
1. Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult
epilepsy. Lancet 2006; 367: 1087-1100, doi: 10.1016/
S0140-6736(06)68477-8.
2. Pezzella M, Striano P, Ciampa C, Errichiello L, Penza P,
Striano S. Severe pulmonary congestion in a near miss at
the first seizure: further evidence for respiratory dysfunction
in sudden unexpected death in epilepsy. Epilepsy Behav
2009; 14: 701-702, doi: 10.1016/j.yebeh.2009.02.012.
3. Scorza FA, Cysneiros RM, de Albuquerque M, Scattolini M,
Arida RM. Sudden unexpected death in epilepsy: an
important concern. Clinics 2011; 66 (Suppl 1): 65-69, doi:
10.1590/S1807-59322011001300008.
4. Bell GS, Sander JW. Sudden unexpected death in epilepsy.
Risk factors, possible mechanisms and prevention: a
reappraisal. Acta Neurol Taiwan 2006; 15: 72-83.
5. Damasceno DD, Savergnini SQ, Gomes ER, Guatimosim S,
Ferreira AJ, Doretto MC, et al. Cardiac dysfunction in rats
prone to audiogenic epileptic seizures. Seizure 2013; 22:
259-266, doi: 10.1016/j.seizure.2013.01.006.
6. Stollberger C, Finsterer J. Cardiorespiratory findings in
sudden unexplained/unexpected death in epilepsy
(SUDEP). Epilepsy Res 2004; 59: 51-60, doi: 10.1016/
j.eplepsyres.2004.03.008.
7. Surges R, Thijs RD, Tan HL, Sander JW. Sudden
unexpected death in epilepsy: risk factors and potential
pathomechanisms. Nat Rev Neurol 2009; 5: 492-504, doi:
10.1038/nrneurol.2009.118.
8. Bealer SL, Little JG. Seizures following hippocampal
kindling induce QT interval prolongation and increased
susceptibility to arrhythmias in rats. Epilepsy Res 2013; 105:
216-219, doi: 10.1016/j.eplepsyres.2013.01.002.
9. Nashef L, Walker F, Allen P, Sander JW, Shorvon SD, Fish
DR. Apnoea and bradycardia during epileptic seizures:
relation to sudden death in epilepsy. J Neurol Neurosurg
Psychiatry 1996; 60: 297-300, doi: 10.1136/jnnp.60.3.297.
10. Kerling F, Dutsch M, Linke R, Kuwert T, Stefan H, Hilz MJ.
Relation between ictal asystole and cardiac sympathetic
dysfunction shown by MIBG-SPECT. Acta Neurol Scand
2009; 120: 123-129, doi: 10.1111/j.1600-0404.2008.01135.x.
11. Scorza FA, Arida RM, Cysneiros RM, Terra VC, Sonoda
EY, de Albuquerque M, et al. The brain-heart connection:
implications for understanding sudden unexpected death in
epilepsy. Cardiol J 2009; 16: 394-399.
12. Glasscock E, Yoo JW, Chen TT, Klassen TL, Noebels JL.
Kv1.1 potassium channel deficiency reveals brain-driven
cardiac dysfunction as a candidate mechanism for sudden
unexplained death in epilepsy. J Neurosci 2010; 30: 5167-
5175, doi: 10.1523/JNEUROSCI.5591-09.2010.
13. Hilz MJ, Platsch G, Druschky K, Pauli E, Kuwert T, Stefan
H, et al. Outcome of epilepsy surgery correlates with
sympathetic modulation and neuroimaging of the heart.
J Neurol Sci 2003; 216: 153-162, doi: 10.1016/j.jns.2003.
07.004.
14. Leutmezer F, Schernthaner C, Lurger S, Potzelberger K,
Baumgartner C. Electrocardiographic changes at the onset
of epileptic seizures. Epilepsia 2003; 44: 348-354, doi:
10.1046/j.1528-1157.2003.34702.x.
15. Mayer H, Benninger F, Urak L, Plattner B, Geldner J, Feucht
M. EKG abnormalities in children and adolescents with
symptomatic temporal lobe epilepsy. Neurology 2004; 63:
324-328, doi: 10.1212/01.WNL.0000129830.72973.56.
16. Almansori M, Ijaz M, Ahmed SN. Cerebral arrhythmia
influencing cardiac rhythm: a case of ictal bradycardia.
Seizure 2006; 15: 459-461, doi: 10.1016/j.seizure.2006.
05.008.
17. Altenmuller DM, Zehender M, Schulze-Bonhage A. High-
grade atrioventricular block triggered by spontaneous and
stimulation-induced epileptic activity in the left temporal
lobe. Epilepsia 2004; 45: 1640-1644, doi: 10.1111/j.0013-
9580.2004.34403.x.
18. Kalume F, Westenbroek RE, Cheah CS, Yu FH, Oakley JC,
Scheuer T, et al. Sudden unexpected death in a mouse
model of Dravet syndrome. J Clin Invest 2013; 123: 1798-
1808, doi: 10.1172/JCI66220.
19. Rossetti AO, Dworetzky BA, Madsen JR, Golub O,
Beckman JA, Bromfield EB. Ictal asystole with convulsive
syncope mimicking secondary generalisation: a depth
electrode study. J Neurol Neurosurg Psychiatry 2005; 76:
885-887, doi: 10.1136/jnnp.2004.051839.
20. Serafini A, Gelisse P, Reana V, Crespel A. Cardiac asystole
during a cluster of right temporo-parietal seizures. Seizure
2011; 20: 181-183, doi: 10.1016/j.seizure.2010.10.031.
21. P-Codrea Tigaran S, Dalager-Pedersen S, Baandrup U,
Dam M, Vesterby-Charles A. Sudden unexpected death in
epilepsy: is death by seizures a cardiac disease? Am J
Forensic Med Pathol 2005; 26: 99-105.
22. Reuterwall C, Hallqvist J, Ahlbom A, De Faire U,
Diderichsen F, Hogstedt C, et al. Higher relative, but lower
absolute risks of myocardial infarction in women than in
men: analysis of some major risk factors in the SHEEP
study. The SHEEP Study Group. J Intern Med 1999; 246:
161-174, doi: 10.1046/j.1365-2796.1999.00554.x.
23. Janszky I, Hallqvist J, Tomson T, Ahlbom A, Mukamal KJ,
Ahnve S. Increased risk and worse prognosis of myocardial
infarction in patients with prior hospitalization for epilepsy -
the Stockholm Heart Epidemiology Program. Brain 2009;
144 J.G.P. Tavares et al.
Braz J Med Biol Res 48(2) 2015 www.bjournal.com.br
132: 2798-2804, doi: 10.1093/brain/awp216.
24. Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SJ,
Kleinrok Z, Turski L. Limbic seizures produced by pilocar-
pine in rats: behavioural, electroencephalographic and
neuropathological study. Behav Brain Res 1983; 9: 315-
335, doi: 10.1016/0166-4328(83)90136-5.
25. Guarini S, Martini MC, Bertolini A. Reperfusion-induced
arrhythmias and lethality are reduced by a 2 KDa heparin
fragment. Life Sci 1995; 57: 967-972, doi: 10.1016/0024-
3205(95)02031-D.
26. Di Diego JM, Antzelevitch C. Cellular basis for ST-segment
changes observed during ischemia. J Electrocardiol 2003;
36 (Suppl): 1-5, doi: 10.1016/j.jelectrocard.2003.09.001.
27. Yan GX, Lankipalli RS, Burke JF, Musco S, Kowey PR.
Ventricular repolarization components on the electrocardio-
gram: cellular basis and clinical significance. J Am Coll
Cardiol 2003; 42: 401-409, doi: 10.1016/S0735-
1097(03)00713-7.
28. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ,
Yellon DM, et al. The Lambeth Conventions: guidelines for
the study of arrhythmias in ischaemia infarction, and
reperfusion. Cardiovasc Res 1988; 22: 447-455, doi:
10.1093/cvr/22.7.447.
29. Huggins CE, Bell JR, Pepe S, Delbridge LM. Benchmarking
ventricular arrhythmias in the mouse - revisiting the
‘Lambeth Conventions’ 20 years on. Heart Lung Circ
2008; 17: 445-450, doi: 10.1016/j.hlc.2008.08.006.
30. Mitchell GF, Jeron A, Koren G. Measurement of heart rate
and Q-T interval in the conscious mouse. Am J Physiol
1998; 274: H747-H751.
31. Tigaran S, Molgaard H, McClelland R, Dam M, Jaffe AS.
Evidence of cardiac ischemia during seizures in drug
refractory epilepsy patients. Neurology 2003; 60: 492-495,
doi: 10.1212/01.WNL.0000042090.13247.48.
32. Opeskin K, Burke MP, Cordner SM, Berkovic SF.
Comparison of antiepileptic drug levels in sudden unex-
pected deaths in epilepsy with deaths from other causes.
Epilepsia 1999; 40: 1795-1798, doi: 10.1111/j.1528-1157.
1999.tb01600.x.
33. Zijlmans M, Flanagan D, Gotman J. Heart rate changes and
ECG abnormalities during epileptic seizures: prevalence
and definition of an objective clinical sign. Epilepsia 2002;
43: 847-854, doi: 10.1046/j.1528-1157.2002.37801.x.
34. Tristani-Firouzi M. The long and short of it: insights into the
short QT syndrome. J Am Coll Cardiol 2014; 63: 1309-1310,
doi: 10.1016/j.jacc.2013.11.021.
35. Bluzaite I, Brazdzionyte J, Zaliunas R, Rickli H, Ammann P.
QT dispersion and heart rate variability in sudden death risk
stratification in patients with ischemic heart disease.
Medicina 2006; 42: 450-454.
Epilepsy-induced electrocardiographic alterations in rats 145
www.bjournal.com.br Braz J Med Biol Res 48(2) 2015
